FOXO Technologies Revenue and Competitors
Estimated Revenue & Valuation
- FOXO Technologies's estimated annual revenue is currently $12.6M per year.
- FOXO Technologies's estimated revenue per employee is $155,000
Employee Data
- FOXO Technologies has 81 Employees.
- FOXO Technologies grew their employee count by 69% last year.
FOXO Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is FOXO Technologies?
Formerly YouSurance and Life Epigenetics. FOXO Technologies is transforming the global longevity insurance industry with a next-generation underwriting protocol and consumer engagement platform based on epigenetic technology and insights. We also offer leading supervised machine learning and artificial intelligence technologies to identify epigenetic biomarkers that measure current states of health and aging.
keywords:N/A
N/A
Total Funding
81
Number of Employees
$12.6M
Revenue (est)
69%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FOXO Technologies News
The second company, FOXO Technologies Inc, develops technology related to actuarial modeling for life insurance policies.
GWG doesn't control its two other primary assetsits stakes in epigenetics technology business FOXO Technologies Inc. and financial-services...
Photograph: NEOGEN/FOXO. Longevity.Technology: The Physicians' Health Study is a large-scale trial that began in 1982 and was...
Other Companies in Minneapolis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.2M | 81 | 7% | N/A |
#2 | $13.2M | 81 | -65% | N/A |
#3 | N/A | 81 | 3% | N/A |
#4 | $3.5M | 81 | 19% | N/A |
#5 | $13.9M | 81 | 8% | N/A |